Medmix Ltd
SIX:MEDX

Watchlist Manager
Medmix Ltd Logo
Medmix Ltd
SIX:MEDX
Watchlist
Price: 8.4 CHF 0.72%
Market Cap: 346.6m CHF
Have any thoughts about
Medmix Ltd?
Write Note

Gross Margin
Medmix Ltd

32.6%
Current
36%
Average
47.1%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
32.6%
=
Gross Profit
156.3m
/
Revenue
479.7m

Gross Margin Across Competitors

Country CH
Market Cap 342.6m CHF
Gross Margin
33%
Country US
Market Cap 199.9B USD
Gross Margin
56%
Country US
Market Cap 191.9B USD
Gross Margin
67%
Country US
Market Cap 140.8B USD
Gross Margin
64%
Country US
Market Cap 134.7B USD
Gross Margin
69%
Country IE
Market Cap 104.7B USD
Gross Margin
65%
Country US
Market Cap 65.9B USD
Gross Margin
45%
Country DE
Market Cap 57.9B EUR
Gross Margin
38%
Country US
Market Cap 44.8B USD
Gross Margin
79%
Country CN
Market Cap 313.8B CNY
Gross Margin
64%
Country US
Market Cap 36.4B USD
Gross Margin
41%
No Stocks Found

Medmix Ltd
Glance View

Market Cap
342.6m CHF
Industry
Health Care

medmix AG designs, develops and produces delivery devices for the mixing, application and injection of liquids for the healthcare, consumer and industrial end-markets. The company is headquartered in Zug, Zug and currently employs 2,101 full-time employees. The firm operates in business areas such as: the dental segment, which provides MIXPAC and transcodent - system solutions that are used to dose, mix and apply various types of dental materials; drug delivery- solutions for the dosage and application of drugs; a surgical segment which provides devices for bone regeneration and tissue healing; an industry segment that specializes in the mixing and dosing of sealants and adhesives through IXPAC , COX and MK; and a beauty segment in which it produces cosmetic applicators through the GEKA brand.

MEDX Intrinsic Value
23.96 CHF
Undervaluation 65%
Intrinsic Value
Price

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
32.6%
=
Gross Profit
156.3m
/
Revenue
479.7m
What is the Gross Margin of Medmix Ltd?

Based on Medmix Ltd's most recent financial statements, the company has Gross Margin of 32.6%.